These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Sensitivity of Proteus mirabilis strains to the bactericidal action of human serum]. Frolov AF; Parkhomenko LV; Lukach IG Mikrobiol Zh (1978); 1986; 48(3):23-6. PubMed ID: 3077431 [No Abstract] [Full Text] [Related]
9. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the Dienes phenomenon in Proteus typing]. Plotkowski MC; Suassuna I Rev Latinoam Microbiol; 1985; 27(1):49-53. PubMed ID: 3892619 [No Abstract] [Full Text] [Related]
11. [Epidemiological application of the Cradock-Watson system for Proteus mirabilis. Comparative study with another system of bacteriocin typing]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Rubio Peiró R; Piédrola Angulo G Rev Latinoam Microbiol; 1985; 27(2):77-81. PubMed ID: 3906814 [No Abstract] [Full Text] [Related]
12. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. Zunino P; Piccini C; Legnani-Fajardo C Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921 [TBL] [Abstract][Full Text] [Related]
13. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246 [No Abstract] [Full Text] [Related]
14. [Epidemiological application of a new bacteriocin typing procedure for Proteus mirabilis]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Gálvez Vargas R; Piédrola Angulo G Rev Latinoam Microbiol; 1985; 27(1):7-10. PubMed ID: 3892620 [No Abstract] [Full Text] [Related]
15. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Alamuri P; Mobley HL Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084 [TBL] [Abstract][Full Text] [Related]
16. [Use of the Dienes phenomenon in epidemiologic practice in intestinal infections]. Orlov VN Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):56-8. PubMed ID: 4616590 [No Abstract] [Full Text] [Related]
17. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections. Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474 [TBL] [Abstract][Full Text] [Related]
18. [Enteropathogenicity of Proteus mirabilis bacteria and pathogenesis of experimental intestinal infections caused by them]. Bidnenko SI; Bernasovskaia EP; Anisimova IuN; Barshteĭn IuA; Mel'nitskaia EV Mikrobiol Zh (1978); 1985; 47(6):81-8. PubMed ID: 3917194 [No Abstract] [Full Text] [Related]